No CrossRef data available.
Article contents
Perceptions et attitudes des personnes âgées souffrant d’insomnie par rapport aux médicaments et aux produits de santé naturels
Published online by Cambridge University Press: 19 September 2025
Résumé
La présente étude de méthode mixte explore les perceptions et attentes relatives aux hypnotiques et produits de santé naturels (PSN) chez les personnes âgées. Vingt-quatre personnes d’en moyenne 76 ans dont 58 % étaient des femmes ont participé à des entrevues semi-structurées. La moitié était des utilisateurs d’hypnotiques. Selon leur score de l’index de sévérité de l’insomnie, 54 % des participants avaient une insomnie légère, 38 % modérée et 8 % sévère. Les participants s’attendaient que les médicaments permettent un endormissement rapide, un sommeil ininterrompu et une augmentation de sa durée. Ils souhaitaient avoir des sensations comme la détente ou l’absence de pensées durant leur sommeil. Les sensations désirées au réveil comprenaient le calme, le bien-être et la satisfaction. Dans l’analyse de combinaison, les thèmes de la quantité de sommeil et le temps de latence court sont des critères d’efficacité les plus fréquemment cités autant chez ceux souffrant d’insomnie légère que modérée à sévère. L’absence d’éveils nocturne était l’autre critère d’efficacité plus fréquemment mentionné chez ceux ayant une insomnie légère alors que la sensation de bien-être au réveil était celui pour ceux ayant une insomnie modérée à sévère.
Abstract
This mixed-method study explores perceptions and expectations on hypnotics and natural health products in older adults. Twenty-four people participated in semi-structured interviews. They had a mean age of 76 years and 58% were female. Half of them used hypnotic drugs. According to the insomnia severity index, 54% had mild, 38% moderate, and 8% severe insomnia. Participants expected hypnotic drugs to give a rapid sleep onset, uninterrupted sleep, and increase sleep duration. While sleeping, they expected to feel relaxed and without invading thoughts. In the morning, they expected to have a sensation of well-being, calm, and satisfaction. In the combination analysis, the most frequent drug efficiency themes were sleep duration and short sleep onset latency regardless of insomnia severity. The other most frequent efficiency theme was the absence of wake after sleep onset for participants with mild insomnia and a sensation of well-being upon awakening for those with moderate to severe insomnia.
Keywords
Information
- Type
- Article
- Information
- Canadian Journal on Aging / La Revue canadienne du vieillissement , Volume 44 , Issue 4 , December 2025 , pp. 482 - 493
- Copyright
- © The Author(s), 2025. Published by Cambridge University Press on behalf of The Canadian Association on Gerontology
Footnotes
This article was originally published with an error in the author list. The error has been corrected and the online HTML and PDF versions updated.
References
Références
Bao, Y. P., Han, Y., Ma, J., Wang, R. J., Shi, L., Wang, T. Y., He, J., Yue, J. L., Shi, J., Tang, X. D., et Lu, L. (2017). Cooccurrence and bidirectional prediction of sleep disturbances and depression in older adults: Meta-analysis and systematic review. Neuroscience and Biobehavioral Reviews, 75, 257–273.CrossRefGoogle ScholarPubMed
Barter, G., et Cormack, M. (1996). The long-term use of benzodiazepines: Patients’ views, accounts and experiences. Family Practice, 13(6), 491–497.CrossRefGoogle ScholarPubMed
Bartlett, S. J., et Ahmed, S. (2017). Montreal accord on patient-reported outcomes (PROs) use series - paper 1: Introduction. Journal of Clinical Epidemiology, 89, 114–118.CrossRefGoogle ScholarPubMed
Bastien, C. H., Vallieres, A., et Morin, C. M. (2001). Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Medicine, 2(4), 297–307.CrossRefGoogle Scholar
Blendon, R. J., DesRoches, C. M., Benson, J. M., Brodie, M., et Altman, D. E. (2001). Americans’ views on the use and regulation of dietary supplements. Archives of Internal Medicine, 161(6), 805–810.CrossRefGoogle ScholarPubMed
Canadian Centre on Substance Use and Addiction. (2022). Sedatives (Canadian Drug Summary). https://www.ccsa.ca/sedatives-canadian-drug-summary.Google Scholar
Chaput, J. P., Yau, J., Rao, D. P., et Morin, C. M. (2018). Prevalence of insomnia for Canadians aged 6 to 79. Health Reports, 29(12), 16–20.Google ScholarPubMed
Cheung, J. M., Bartlett, D. J., Armour, C. L., Ellis, J. G., et Saini, B. (2016). People with insomnia: Experiences with sedative hypnotics and risk perception. Health Expectations, 19(4), 935–947.CrossRefGoogle ScholarPubMed
Cheung, J. M. Y., Bartlett, D. J., Armour, C. L., Laba, T. L., et Saini, B. (2018). To drug or not to drug: A qualitative study of patients’ decision-making processes for managing insomnia. Behavioral Sleep Medicine, 16(1), 1–26.CrossRefGoogle ScholarPubMed
Creswell, J. W., et Creswell, J. D. (2023). Research design : Qualitative, quantitative, and mixed methods approaches (6th ed). SAGE.Google Scholar
Crocq, M. A., Guelfi, J. D., et American Psychiatric, A. (2015). DSM-5: Manuel diagnostique et statistique des troubles mentaux (5th ed). Elsevier Masson.Google Scholar
Dang Vu, T. T., et Morin, C. (2019). L’évaluation et la prise en charge de l’insomnie chez la personne âgée. Société québécoise de gériatrie. https://www.sqgeriatrie.org/dl2.php?file=2019-10_l39evaluation_et_la_prise_en_charge_de_l39insomnie_chez_la_perso.pdf.Google Scholar
De Crescenzo, F., D’Alo, G. L., Ostinelli, E. G., Ciabattini, M., Di Franco, V., Watanabe, N., Kurtulmus, A., Tomlinson, A., Mitrova, Z., Foti, F., Del Giovane, C., Quested, D. J., Cowen, P. J., Barbui, C., Amato, L., Efthimiou, O., et Cipriani, A. (2022). Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: A systematic review and network meta-analysis. Lancet, 400(10347), 170–184.CrossRefGoogle ScholarPubMed
Downing, N. E., et Nevill, D. D. (1983). Conceptions of psychological health: The role of gender and sex-role identity [comparative study]. British Journal of Social Psychology, 22(Pt 2), 171–173.CrossRefGoogle ScholarPubMed
Edinger, J. D., Arnedt, J. T., Bertisch, S. M., Carney, C. E., Harrington, J. J., Lichstein, K. L., Sateia, M. J., Troxel, W. M., Zhou, E. S., Kazmi, U., Heald, J. L., et Martin, J. L. (2021). Behavioral and psychological treatments for chronic insomnia disorder in adults: An American Academy of sleep medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 17(2), 255–262.CrossRefGoogle ScholarPubMed
Feinsilver, S. H. (2021). Normal and abnormal sleep in the elderly. Clinics in Geriatric Medicine, 37(3), 377–386.CrossRefGoogle ScholarPubMed
Fitzgerald, T., et Vietri, J. (2015). Residual effects of sleep medications are commonly reported and associated with impaired patient-reported outcomes among insomnia patients in the United States. Sleep Disorders Print, 2015, 607148.Google ScholarPubMed
Fofana, F., Bazeley, P., et Regnault, A. (2020). Applying a mixed methods design to test saturation for qualitative data in health outcomes research. PLoS One, 15(6), e0234898.CrossRefGoogle ScholarPubMed
Gale, N. K., Heath, G., Cameron, E., Rashid, S., et Redwood, S. (2013). Using the framework method for the analysis of qualitative data in multi-disciplinary health research [research support, non-U.S. gov’t]. BMC Medical Research Methodology, 13, 117.CrossRefGoogle ScholarPubMed
Kosinski, M., Nelson, L. M., Stanford, R. H., Flom, J. D., et Schatz, M. (2024). Patient-reported outcome measure development and validation: A primer for clinicians. The Journal of Allergy & Clinical Immunology in Practice, 22, 22.Google Scholar
Krakow, B., Ulibarri, V. A., et Romero, E. (2010). Persistent insomnia in chronic hypnotic users presenting to a sleep medical center: A retrospective chart review of 137 consecutive patients. Journal of Nervous & Mental Disease, 198(10), 734–741.CrossRefGoogle Scholar
Kuriyama, A., et Tabata, H. (2017). Suvorexant for the treatment of primary insomnia: A systematic review and meta-analysis. Sleep Medicine Reviews, 35, 1–7.CrossRefGoogle ScholarPubMed
Landis, J. R., et Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159–174.CrossRefGoogle ScholarPubMed
Lin, C. L., Lin, C. P., et Sun, J. C. (2022). Experiences of middle-aged and older Taiwanese adults with chronic insomnia: A descriptive qualitative study. Journal of Gerontological Nursing, 48(11), 21–28.CrossRefGoogle ScholarPubMed
Moloney, M. E. (2017). Sometimes, it’s easier to write the prescription’: Physician and patient accounts of the reluctant medicalisation of sleeplessness. Sociology of Health et Illness, 39(3), 333–348.CrossRefGoogle ScholarPubMed
Montgomery, S. A., et Åsberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134(4), 382–389.CrossRefGoogle ScholarPubMed
Morin, C. M., Belleville, G., Belanger, L., et Ivers, H. (2011). The insomnia severity index: Psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep, 34(5), 601–608.CrossRefGoogle ScholarPubMed
Morin, C. M., et Jarrin, D. C. (2022). Epidemiology of insomnia: Prevalence, course, risk factors, and public health burden. Sleep Medicine Clinics, 17(2), 173–191.CrossRefGoogle ScholarPubMed
Patrick, D. L., Burke, L. B., Powers, J. H., Scott, J. A., Rock, E. P., Dawisha, S., O’Neill, R., et Kennedy, D. L. (2007). Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value in Health, 10(Suppl 2), S125–S137.CrossRefGoogle ScholarPubMed
Pudrovska, T. (2015). Gender and health control beliefs among middle-aged and older adults. Journal of Aging and Health, 27(2), 284–303.CrossRefGoogle ScholarPubMed
Riemann, D., Espie, C. A., Altena, E., Arnardottir, E. S., Baglioni, C., Bassetti, C. L. A., Bastien, C., Berzina, N., Bjorvatn, B., Dikeos, D., Dolenc Groselj, L., Ellis, J. G., Garcia-Borreguero, D., Geoffroy, P. A., Gjerstad, M., Gonçalves, M., Hertenstein, E., Hoedlmoser, K., Hion, T., … Spiegelhalder, K. (2023). The European insomnia guideline: An update on the diagnosis and treatment of insomnia 2023. Journal of Sleep Research, 32(6), e14035.CrossRefGoogle ScholarPubMed
Sateia, M. J. (2014). International classification of sleep disorders-third edition. Chest, 146(5), 1387–1394.CrossRefGoogle ScholarPubMed
Sirdifield, C., Chipchase, S. Y., Owen, S., et Siriwardena, A. N. (2017). A systematic review and meta-synthesis of patients’ experiences and perceptions of seeking and using benzodiazepines and Z-drugs: Towards safer prescribing. The Patient: Patient-Centered Outcomes Research, 10(1), 1–15.CrossRefGoogle ScholarPubMed
Sweetman, A., Osman, A., Lack, L., Crawford, M., et Wallace, D. (2023). Co-morbid insomnia and sleep apnea (COMISA): Recent research and future directions [review]. Current Opinion in Pulmonary Medicine, 29(6), 567–573.CrossRefGoogle ScholarPubMed
US FDA. (2009). Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims.Google Scholar
Weldring, T., et Smith, S. M. S. (2013). Article commentary: Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs). Health Services Insights, 6, HSI.S11093.CrossRefGoogle Scholar
Zhao, X., Zhang, D., Wu, M., Yang, Y., Xie, H., Jia, J., Li, Y., Su, Y. (2019). Depressive symptoms mediate the association between insomnia symptoms and health-related quality of life and synergistically interact with insomnia symptoms in older adults in nursing homes. Psychogeriatrics:The Official Journal of the Japanese Psychogeriatric Society, 19(6), 584–590.CrossRefGoogle ScholarPubMed
Nguyen et al. supplementary material
Nguyen et al. supplementary material
File
359.1 KB
A correction has been issued for this article:
Linked content
Please note a has been issued for this article.